Tune in to the latest episode of the Life Sciences Connect podcast, where you will find Sara Siegel’s fireside chat about all things Global Healthcare Episode 25 welcomes the new Global Head of Health and previous guest, Sara Siegel who discusses with Karen the various challenges impacting global healthcare systems today, their hopes and ambitions for the future.

Karen and the team explore the findings from the Future of Diagnostic Series   Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging. 

Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend

In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the workforce. Join Karen Taylor, Ed Roddis and Emma Horrell as they dissect the findings from the latest State of the State report to bring you a view of the state from the people who use and the people who run it: State of the State

On this episode of Life Sciences Connect podcast, we bring the discussion of emission reduction to the forefront. Hear our guest discuss further: James Gregson – UK’s Life Sciences & Healthcare industry leader At the start of October we launched our report: Embedding environmental sustainability into pharma’s DNA. In this episode of we explore the pressing challenges facing pharma in achieving ambitious environmental sustainability targets and evaluate ways of making progress through easy wins across the value chain, culture changes and new investment. These quick wins can provide the license to make transformative, fundamental changes that are necessary to achieve pharma’s targets. Listen to hear more on this topic.

On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts: Andy Flockhart, UK MedTech Leader Guido Baechler, CEO of Mainz Biomed And of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role in revolutionising healthcare. Driving the need for innovation are growing and ageing populations, the increasing prevalence of non-communicable diseases and chronic conditions, workforce shortages and an increasingly knowledgeable and empowered consumer base Listen to hear more on this topic.

Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much more. To learn more about health equity and other important issues facing public health in the UK, explore out Future of Public Health Series

Listen to episode 18 of the Life Sciences Connect podcast where we talk to specialists about Hospital Activation, how we are breaking from the traditional approach and what the future holds.

Listen to episode 17 of the Life Sciences Connect podcast here where we continue with the Future of Public Health series and dive further into the report- Evaluating the role of employers in reducing the public health gap: Improving the health and productivity of employees.

In episode sixteen of the Life Science Connect podcast, we dive into the conversation around our fourth report in our Future of Public Health series; Negating the gap - Preventing ill health and promoting healthy behaviours. Joining our host Karen Taylor, Research Director of the Deloitte UK Centre for Health Solutions, is Dr Karen Kirkham, Chief Medical Officer and Lead Partner for Integration in Deloitte’s Health and Social Care team and Sara Siegel, Deloitte’s UK and EMEA Head of Healthcare as we examine the crucial role of public health in health protection, ill-health prevention and in promoting healthy behaviours. Despite a wealth of evidence that investing in prevention is fundamental to a resilient and sustainable health system, the UK, like most other countries, spends less than five per cent of healthcare funding on preventative services. Listen to hear more about this debate and see what some of the experts have to say on this topic